In a nationally representative cohort, adolescents and young adults with optimal cardiovascular health later had lower risks of gestational diabetes and hypertensive disorders of pregnancy than peers with...
A study presented at the American College of Cardiology's 74th Annual Scientific Session found that GLP-1RA use in patients with psoriasis was linked to a lower incidence of major adverse cardiovascular...
A new analysis found no difference in cardiovascular event rates between immediate and deferred antiretroviral therapy initiation among adults with HIV who had high CD4+ counts and low baseline...
A retrospective cohort study suggested that colchicine prophylaxis at urate-lowering therapy initiation may lower cardiovascular event risk in patients with gout.
A randomized clinical trial found that a nurse-led intervention strategy could improve systolic blood pressure and non-high-density lipoprotein cholesterol in patients with HIV, reducing their risk of...
On March 8, the FDA approved the injectable weight loss medication, semaglutide, for reducing the risk of cardiovascular events such as heart attack, stroke, and cardiovascular death in adults with heart...
In a prospective cohort study, researchers found associations between cardiovascular disease risk factors and the development of musculoskeletal disorders.
Did you get the chance to view our Multidisciplinary Roundtable on some hot topics in treating patients with HIV? Here are some highlights that you may have missed.
